Nantahala Capital Management, LLC 13D and 13G filings for Zevra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Sale | 2024-12-31 | 13G | Zevra Therapeutics, Inc. ZVRA | Nantahala Capital Management, LLC | 2,340,333 4.380% | -583,688 (-19.96%) | Filing |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Zevra Therapeutics, Inc. ZVRA | Nantahala Capital Management, LLC | 2,924,021 5.557% | 470,616 (+19.18%) | Filing |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | Zevra Therapeutics, Inc. ZVRA | Nantahala Capital Management, LLC | 2,453,405 6.200% | 2,453,405 (New Position) | Filing |